(195 days)
Not Found
No
The document does not mention AI, deep neural networks (DNN), or machine learning (ML), nor does it describe any associated training or test sets, which would be expected if an AI model were present. The device description focuses on its electrical specifications and laser functionality.
Yes
The device is intended for surgical procedures like incision, excision, vaporization, ablation, hemostasis, and coagulation of body soft tissue, which are therapeutic actions.
No.
The device's intended use is for surgical applications like incision, excision, vaporization, ablation, hemostasis, and coagulation, all of which are treatment-oriented procedures rather than diagnostic ones.
No
The device description, intended use, and performance studies clearly indicate that the DEKA BlueBeam is a hardware device (a diode laser) designed for surgical applications, requiring electrical specifications and various hardware safety and performance tests. While software verification and validation are mentioned, they pertain to the software functions of this physical device, not a standalone software-only product.
No
The device is a surgical laser for incision, excision, vaporization, ablation, hemostasis, and coagulation of body soft tissue. It is designed for therapeutic or surgical intervention, not for in vitro examination of specimens derived from the human body.
N/A
Intended Use / Indications for Use
The DEKA BlueBeam is a medical device intended for incision, excision, vaporization, ablation, hemostasis and coagulation of body soft tissue.
Product codes
GEX
Device Description
The DEKA BLUEBEAM is a diode laser engineered to enhance performance in surgical applications. The DEKA BLUEBEAM electrical specifications are: 100-230V~, 50/60Hz, 300VA.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
body soft tissue
Indicated Patient Age Range
Not Found
Intended User / Care Setting
Not Found
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies
None
Key Metrics
Not Found
Predicate Device(s)
Reference Device(s)
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information
Not Found
§ 878.4810 Laser surgical instrument for use in general and plastic surgery and in dermatology.
(a)
Identification. (1) A carbon dioxide laser for use in general surgery and in dermatology is a laser device intended to cut, destroy, or remove tissue by light energy emitted by carbon dioxide.(2) An argon laser for use in dermatology is a laser device intended to destroy or coagulate tissue by light energy emitted by argon.
(b)
Classification. (1) Class II.(2) Class I for special laser gas mixtures used as a lasing medium for this class of lasers. The devices subject to this paragraph (b)(2) are exempt from the premarket notification procedures in subpart E of part 807 of this chapter, subject to the limitations in § 878.9.
FDA 510(k) Clearance Letter - DEKA BLUEBEAM
Page 1
U.S. Food & Drug Administration
10903 New Hampshire Avenue
Silver Spring, MD 20993
www.fda.gov
Doc ID # 04017.07.05
June 12, 2025
El.En. S.p.A.
Paolo Peruzzi
Regulatory Affairs Manager
Via Baldanzese 17
Calenzano, Fl 50141
Italy
Re: K243683
Trade/Device Name: Deka Bluebeam
Regulation Number: 21 CFR 878.4810
Regulation Name: Laser Surgical Instrument For Use In General And Plastic Surgery And In Dermatology
Regulatory Class: Class II
Product Code: GEX
Dated: May 15, 2025
Received: May 15, 2025
Dear Paolo Peruzzi:
We have reviewed your section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (the Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. Although this letter refers to your product as a device, please be aware that some cleared products may instead be combination products. The 510(k) Premarket Notification Database available at https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm identifies combination product submissions. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of
Page 2
K243683 - Paolo Peruzzi Page 2
Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Additional information about changes that may require a new premarket notification are provided in the FDA guidance documents entitled "Deciding When to Submit a 510(k) for a Change to an Existing Device" (https://www.fda.gov/media/99812/download) and "Deciding When to Submit a 510(k) for a Software Change to an Existing Device" (https://www.fda.gov/media/99785/download).
Your device is also subject to, among other requirements, the Quality System (QS) regulation (21 CFR Part 820), which includes, but is not limited to, 21 CFR 820.30, Design controls; 21 CFR 820.90, Nonconforming product; and 21 CFR 820.100, Corrective and preventive action. Please note that regardless of whether a change requires premarket review, the QS regulation requires device manufacturers to review and approve changes to device design and production (21 CFR 820.30 and 21 CFR 820.70) and document changes and approvals in the device master record (21 CFR 820.181).
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical device-related adverse events) (21 CFR Part 803) for devices or postmarketing safety reporting (21 CFR Part 4, Subpart B) for combination products (see https://www.fda.gov/combination-products/guidance-regulatory-information/postmarketing-safety-reporting-combination-products); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820) for devices or current good manufacturing practices (21 CFR Part 4, Subpart A) for combination products; and, if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR Parts 1000-1050.
All medical devices, including Class I and unclassified devices and combination product device constituent parts are required to be in compliance with the final Unique Device Identification System rule ("UDI Rule"). The UDI Rule requires, among other things, that a device bear a unique device identifier (UDI) on its label and package (21 CFR 801.20(a)) unless an exception or alternative applies (21 CFR 801.20(b)) and that the dates on the device label be formatted in accordance with 21 CFR 801.18. The UDI Rule (21 CFR 830.300(a) and 830.320(b)) also requires that certain information be submitted to the Global Unique Device Identification Database (GUDID) (21 CFR Part 830 Subpart E). For additional information on these requirements, please see the UDI System webpage at https://www.fda.gov/medical-devices/device-advice-comprehensive-regulatory-assistance/unique-device-identification-system-udi-system.
Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to https://www.fda.gov/medical-devices/medical-device-safety/medical-device-reporting-mdr-how-report-medical-device-problems.
For comprehensive regulatory information about medical devices and radiation-emitting products, including information about labeling regulations, please see Device Advice (https://www.fda.gov/medical-devices/device-advice-comprehensive-regulatory-assistance) and CDRH Learn
Page 3
K243683 - Paolo Peruzzi Page 3
(https://www.fda.gov/training-and-continuing-education/cdrh-learn). Additionally, you may contact the Division of Industry and Consumer Education (DICE) to ask a question about a specific regulatory topic. See the DICE website (https://www.fda.gov/medical-devices/device-advice-comprehensive-regulatory-assistance/contact-us-division-industry-and-consumer-education-dice) for more information or contact DICE by email (DICE@fda.hhs.gov) or phone (1-800-638-2041 or 301-796-7100).
Sincerely,
TANISHA L. HITHE -S
Digitally signed by TANISHA L. HITHE -S
Date: 2025.06.12 14:26:38 -04'00'
Tanisha Hithe
Assistant Director
DHT4A: Division of General Surgery Devices
OHT4: Office of Surgical and Infection Control Devices
Office of Product Evaluation and Quality
Center for Devices and Radiological Health
Enclosure
Page 4
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
Indications for Use
Form Approved: OMB No. 0910-0120
Expiration Date: 07/31/2026
See PRA Statement below.
Submission Number (if known): K243683
Device Name: DEKA BLUEBEAM
Indications for Use (Describe)
The DEKA BlueBeam is a medical device intended for incision, excision, vaporization, ablation, hemostasis and coagulation of body soft tissue.
Type of Use (Select one or both, as applicable)
☒ Prescription Use (Part 21 CFR 801 Subpart D)
☐ Over-The-Counter Use (21 CFR 801 Subpart C)
CONTINUE ON A SEPARATE PAGE IF NEEDED.
This section applies only to requirements of the Paperwork Reduction Act of 1995.
DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.
The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:
Department of Health and Human Services
Food and Drug Administration
Office of Chief Information Officer
Paperwork Reduction Act (PRA) Staff
PRAStaff@fda.hhs.gov
"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."
Page 5
510(k) Summary
K243683
DEKA BLUEBEAM
Submitter:
El.En. S.p.A.
Via Baldanzese, 17
50041 Calenzano (FI), Italy
Contact:
Paolo Peruzzi
Regulatory Affairs Manager & Official Correspondent
Phone: +39.055.8826807
E-mail: p.peruzzi@elen.it
Date Summary Prepared:
June 12th, 2025
Device Trade Name:
DEKA BLUEBEAM
Common Name:
Medical Laser
Regulation Number:
21 CFR 878.4810
Regulation Name:
Laser Surgical Instrument for use in General and Plastic and in Dermatology
Regulatory Class:
Class II
Product Code:
GEX
Predicate Devices:
Primary predicate: Wolf 445nm (K192272)
Page 6
Device Description:
The DEKA BLUEBEAM is a diode laser engineered to enhance performance in surgical applications. The DEKA BLUEBEAM electrical specifications are: 100-230V~, 50/60Hz, 300VA.
Indications for Use:
The DEKA BLUEBEAM is a medical device intended for incision, excision, vaporization, ablation, hemostasis and coagulation of body soft tissue.
Comparison with The Predicate Device:
The DEKA BLUEBEAM is as safe, as effective, and performs as well as the legally marketed predicate device (K192272):
| Device Trade Name | Proposed Device
DEKA BlueBeam | Predicate Device
Wolf 445nm
A.R.C. Laser GmbH
(K192272) | Comment |
|---|---|---|---|
| Indications for Use | Intended for incision, excision, vaporization, ablation, hemostasis and coagulation of body soft tissue | intended for use in incision/excision, vaporization, ablation, hemostasis and coagulation of soft tissue | Identical |
| Regulation number | 21 CFR 878.4810 | 21 CFR 878.4810 | Identical |
| Product Code | GEX | GEX | Identical |
| Laser Type | Diode Laser | Diode Laser | Identical |
| Laser Power | From 0.5W to 10W | From 0.5W to 10W | Identical |
| Wavelength | 445nm | 445nm | Identical |
| Laser Class | 4 | 4 | Identical |
| Operation mode | Continuous Wave (CW), Pulsed mode (PW) or Single Pulse | Pulsed, Continuous Wave (CW) or Single Pulse (SP) | Identical |
| Pulse length / duration | 1 ms to 2 s | ≤ 4 Watt: 1 ms to 45 sec and CW
4 Watt: 1 ms to 60 ms | Subset |
Page 7
| Device Trade Name | Proposed Device
DEKA BlueBeam | Predicate Device
Wolf 445nm
A.R.C. Laser GmbH
(K192272) | Comment |
|---|---|---|---|
| Pulse frequency | 0.25 to 500 Hz and Single Pulse | ≤ 4 Watt: 0.01 Hz to 500 Hz and SP
4 Watt: 0.02 Hz to 6.6 Hz and SP | Subset |
| Spot size | 0.27 to 0.6 mm | 0.3 to 0.6 mm | Similar |
| Aiming beam | 520 nm, 3.2mW | 532 nm,